Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today announced the appointment of Gabrielle ‘Gabi’ Raia to the newly created position of Senior Vice President of Discovery and Clinical Sales. In this role, Gabi will be responsible for managing the existing business with research customers as well as facilitating the adoption of 3D genomics into the translational and clinical communities, including healthcare providers.

“Knowledge of the spatial organization of DNA within cells unravels powerful use cases for scientific and translational research, but until recently, this technology was only accessible to specialized laboratories with sophisticated bioinformatics capabilities,” said Gabi Raia, Senior Vice President, Discovery and Clinical Sales at Arima Genomics. “Arima Genomics has democratized the 3D genomics technology and now has the opportunity to transform the market for precision oncology by offering this powerful new tool for identifying actionable gene and proximity fusions from otherwise driver-negative tissue samples.”

Gabi brings over 26 years of genomics leadership and sales experience across research-oriented and clinically focused companies. Most recently, she was Senior Vice President, Global Sales for Genapsys and Sequencing Health, responsible for strategic market assessment, global launch planning, and scaling the sales organization. Gabi previously held senior sales leadership roles with Invitae following their acquisition of ArcherDX, Illumina, Life Technologies, PacBio, and Affymetrix. She holds a B.S. in Molecular and Cell Biology from Penn State University.

“Gabi will play an indispensable role in facilitating the adoption of 3D genomics by research and clinical audiences, ultimately helping speed the utilization of our technology to benefit patients with cancer,” said Siddarth Selvaraj, Ph.D., Chief Executive Officer of Arima Genomics. “Gabi deeply understands the genomics landscape and how to help both our translational and clinical customers overcome the barriers they face in adopting new technologies.”

About Arima Genomics

Arima Genomics, Inc. is advancing human health and the life sciences by revealing comprehensive genomic insights. Researchers and clinicians use Arima Genomics’ innovative products and services to gain unparalleled access to the three-dimensional (3D) organization of the genome. This advanced technology enables improvements in human health through identification of biomarkers, an expanded understanding of disease mechanisms, development of novel therapeutic approaches, and solutions for patient management. To learn more, visit www.arimagenomics.com and connect with us on Twitter, LinkedIn, and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230501005251/en/